Connect with us

Spread & Containment

Most Active Stocks Today? 5 Chinese Stocks For Your Watchlist

With improving sentiments, could these Chinese stocks be worth a closer look?
The post Most Active Stocks Today? 5 Chinese Stocks For Your Watchlist appeared…

Published

on

5 Top Chinese Stocks To Watch Right Now

As we begin another week of trading in the stock market, Chinese stock continues to draw traction among investors. For now, investors appear to have a sense of optimism due to the easing of regulatory crackdowns and lockdown restrictions within the country. After two painful months of lockdown to halt the outbreak of the Omicron variant, Beijing and Shanghai are finally returning to normalcy. Not to mention, the Chinese government unveiled a stimulus package late last month, which includes measures to encourage consumption. Hence, it should not be surprising if investors are making their list of top Chinese stocks to buy this week. 

Furthermore, Chinese regulators are concluding probes into ride-hailing giant Didi Global (NYSE: DIDI). It appears that the company’s app will be back on domestic app stores as early as this week, according to Wall Street Journal. In light of this, DIDI stock is rising by over 50% on today’s opening bell. Aside from that, reports are also suggesting that regulators are planning to allow apps of logistics platform Full Truck Alliance (NYSE: YMM) back on the app store this week. Considering all these, here are five Chinese stocks to watch in the stock market today

Chinese Stocks To Watch This Week

Nio

First up, we have one of the leading electric vehicle (EV) companies in China, Nio. The company also develops battery swapping technologies and autonomous driving technologies. Moreover, Nio recently entered a partnership with Advanced Micro Devices (NASDAQ: AMD). As part of the collaboration, Nio will use AMD’s EPYC family of processors to speed up its AI deep learning training and shorten product development cycles. For now, the chips will only be used for vehicle development and not the production of vehicles. 

Last week, the company announced its vehicle deliveries for May 2022. Nio delivered 7,024 vehicles, up 5% compared to the same period last year. While these figures may not be wildly impressive, it is suggestive that Nio is gradually recovering from the impact of coronavirus outbreaks in China. Investors should note that vehicle deliveries were largely constrained by the corresponding preventive measures over the past few months. Moving forward, Nio plans to ramp up the production capacity by working closely with supply chain partners. All in all, do you think NIO stock can build on its current momentum?

NIO Stock chart
Source: TD Ameritrade TOS

[Read More] Stock Market Today: Dow Jones, S&P 500 Open Higher; Spirit Stock In Focus In Bidding War

Xpeng

Similar to Nio, Xpeng is another top EV company in China. As of now, its primary products are vehicles such as the G3 SUV and the P7 sports sedan. Xpeng also aims to develop a full-stack autonomous driving technology, in-car intelligent operating system, and core vehicle systems. All this is possible through its proprietary software, core hardware, and data technologies. XPEV stock has climbed more than 10% over the past month. 

As with most Chinese EV companies, Xpeng also recently announced its vehicle delivery updates for May 2022. Impressively, Xpeng delivered 10,125 Smart EVs, representing an increase of 78% year-over-year. As a result, the company has now delivered 53,688 vehicles since the start of the year, up 122% year-over-year. Prospective investors should note that Xpeng has resumed double-shift production at its Zhaoqing plant as supply chains and key manufacturing areas in China are gradually recovering. So, would you consider adding XPEV stock to your watchlist? 

XPEV Stock
Source: TD Ameritrade TOS

Futu

Futu is a digitized brokerage and wealth management for investors around the globe. For those unaware, its advanced investing platform has transformed the investing experience and primarily serves the emerging affluent population. The company provides investment services through its proprietary digital platforms, Futubull and moomoo, each a highly integrated application accessible through any mobile device, tablet, or desktop. FUTU stock is up more than 25% as of 10:21 a.m. ET. This came after the company reported its first-quarter business updates. 

Despite all the market volatility, the company still achieved solid first quarter growth in multiple metrics. During the quarter, the total number of users on moomoo and Futubulll was 18.1 million, up 27.1% year-over-year. Meanwhile, its total number of paying clients was 1,326,163, representing an increase of 67.9% compared to the prior year’s quarter. All things considered, Futu demonstrated its resilience with several upbeat highlights. With that in mind, would you bank on the future of FUTU stock?

FUTU stock chart
Source: TD Ameritrade TOS

[Read More] Best Long Term Stocks To Buy Now? 4 Semiconductor Stocks To Watch

BYD

Following that, let us look at the transportation company, BYD. Its primary business involves the manufacture and sales of transportation equipment, including electric vehicles and buses. Besides that, BYD also engages in the manufacture and sales of electronic parts and components and electronic devices for daily use. BYDDF stock has been on a bullish momentum, rising more than 30% within the past month. 

Recently, rumors are suggesting that BYD could be in the process of acquiring six lithium mines in Africa. Those familiar with the industry would be aware that lithium is an important material to make batteries. The six lithium mines may have more than 25 million tons of ore with a 2.5% lithium oxide grade. This translates to up to 1 million tons of lithium carbonate. Should the deal materialize, it could strengthen BYD’s hold on the supply of a key material. For now, these are all speculative and investors should tread carefully before making any investment decisions. Thus, would you consider BYDDF stock as a top Chinese stock to watch? 

BYDDF stock
Source: TD Ameritrade TOS

NetEase 

Last but not least, let us look at the Chinese tech company, NetEase. The company has an Online Game Service segment that engages in the development and operation of online games. Some of its notable games include Westward Journey, the Onmyoji series, and many more. Aside from that, it also has an Innovative Businesses and Others segment that provides Netease Cloud Music, Netease Mail, and Netease News. In May, there were several positive updates by the company that could spark the interest of investors. 

For starters, NetEase unveiled June 23 as the official release date for Diablo Immortal, a highly anticipated game among gaming enthusiasts. On a sense of scale, pre-registration for the game has surpassed 15 million in China across all platforms. On top of that, NetEase also announced its first-quarter earnings report. Its net revenue for the quarter was $3.7 billion, up 14.8% year-over-year. Out of which, Online game services contributed $2.7 billion while Cloud Music contributed $326.1 million. Safe to say, all its business lines are making progress as the company looks forward to creating more value for its shareholders. Considering these factors, would NTES stock be a viable long-term investment?

NTES stock chart
Source: TD Ameritrade TOS

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post Most Active Stocks Today? 5 Chinese Stocks For Your Watchlist appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Spread & Containment

Sex work is real work: Global COVID-19 recovery needs to include sex workers

Societally, we need to recognize that sex workers have agency and deserve the same respect, dignity and aid as any other person selling their labour.

Published

on

Globally, sex workers have been left to fend for themselves during the pandemic with little to no support from the government. (AP Photo/Bikas Das)

During the pandemic, business shifted from in person to work-from-home, which quickly became the new normal. However, it left many workers high and dry, especially those with less “socially acceptable” occupations.

The pandemic has adversely impacted sex workers globally and substantially increased the precariousness of their profession. And public health measures put in place made it almost impossible for sex workers to provide any in-person service.

Although many people depend on sex work for survival, its criminalization and policing stigmatizes sex workers.

Research shows that globally, sex workers have been left behind and in most cases excluded from government economic support initiatives and social policies. There needs to be an intersectional approach to global COVID-19 recovery that considers everyone’s lived realities. We propose policy recommendations that treat sex work as decent work and that centre around the lived experiences and rights of those in the profession.

Sex work and the pandemic

The United Nations Population Fund (UNFPA) recently reported that apart from income-loss, the pandemic has increased pre-existing inequalities for sex workers.

In a survey conducted in Eastern and Southern Africa, the UNFPA found that during the pandemic, 49 per cent of sex workers experienced police violence (including sexual violence) while 36 per cent reported arbitrary arrests. The same survey reported that more than 50 per cent of respondents experienced food and housing crises.

Lockdowns and border closures adversely impacted Thailand’s tourism industry which relies partially on the labour of sex workers.


Read more: Sex workers are criminalized and left without government support during the coronavirus pandemic


In the Asia Pacific, sex workers reported having limited access to contraceptives and lubricants along with reduced access to harm reduction resources. Lockdowns also disrupted STI or HIV testing services, limiting sex workers’ access to necessary healthcare.

In North America, sex workers have been excluded from the government’s recovery response. And many began offering online services to sustain themselves.

A woman stands backlit next to a dimly lit bus that reads 'Thailand' with green lighting.
Sex workers stand in a largely shut-down red light area in Bangkok, Thailand on March 26, 2020. (AP Photo/Gemunu Amarasinghe)

Government vs. community response

Globally, sex workers have been left to fend for themselves during the pandemic with little to no support from the government. But communities themselves have been rallying.

Elene Lam, founder of Butterfly, an Asian migrant sex organization in Canada, talks about the resilience of sex wokers during the pandemic.

She says organizations like the Canadian Alliance for Sex Work Law Reform are working in collaboration with Amnesty International to mobilize income support and resources to help sex workers in Canada.

Organizations in the United Kingdom, Germany, India and Spain have also set up emergency support funds. And some sex worker organizations have developed community-specific resources for providing services both in person and online during the pandemic.

Global recovery needs to include sex workers

The International Labour Organization’s “Decent Work Agenda” emphasizes productive employment and decent working conditions as being the driving force behind poverty reduction.

Sociologist Cecilia Benoit explains that sex work often becomes a “livelihood strategy” in the face of income and employment instability. She says that like other personal service workers, sex workers also should be able to practice without any interference or violence.

In order to have an inclusive COVID-19 recovery for all, governments need to work to extend social guarantees to sex workers — so far they haven’t.

As pandemic restrictions disappear, it is crucial to ensure that everyone involved in sex work is protected under the law and has access to accountability measures.

A woman stands wearing a mask with a safety vest on in front of a collage of scantily clad women and a sign that reads 'nude women non stop'
A volunteer helps out at Zanzibar strip club during a low-barrier vaccination clinic for sex workers in Toronto in June 2021. THE CANADIAN PRESS/Frank Gunn

Recommendations

As feminist researchers, we propose that sex work be brought under the broader agenda of decent work so that the people offering services are protected.

  1. Governments need to have a legal mandate for preventing sexual exploitation.

  2. Law enforcement staff need to be trained in better responding to the needs of sex workers. To intervene in and address situations of abuse or violence is critical to ensure workplace safety and harm reduction.

  3. Awareness and educational campaigns need to focus on destigmatizing sex work.

  4. Policy-makers need to incorporate intersectionality as a working principle in identifying and responding to the different axes of oppression and marginalization impacting LGBTQ+ and racialized sex workers.

  5. Engagement with sex workers and human rights organizations need to happen when designing aid support to ensure that an inclusive pathway for recovery is created.

  6. Globally, there needs to be a steady commitment towards destigmatizing sex workers and their services.

Despite the gradual waning of pandemic restrictions, sex workers continue to face the dual insecurity of social discrimination and loss of income support. Many are still finding it difficult to stay afloat and sustain themselves.

Societally, we need to recognize that sex workers have agency and deserve the same respect, dignity and aid as any other person selling their labour.

The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Read More

Continue Reading

Government

OU researchers award two NSF pandemic prediction and prevention projects

Two groups of researchers at the University of Oklahoma have each received nearly $1 million grants from the National Science Foundation as part of its…

Published

on

Two groups of researchers at the University of Oklahoma have each received nearly $1 million grants from the National Science Foundation as part of its Predictive Intelligence for Pandemic Prevention initiative, which focuses on fundamental research and capabilities needed to tackle grand challenges in infectious disease pandemics through prediction and prevention.

Credit: Photo provided by the University of Oklahoma.

Two groups of researchers at the University of Oklahoma have each received nearly $1 million grants from the National Science Foundation as part of its Predictive Intelligence for Pandemic Prevention initiative, which focuses on fundamental research and capabilities needed to tackle grand challenges in infectious disease pandemics through prediction and prevention.

To date, researchers from 20 institutions nationwide were selected to receive an NSF PIPP Award. OU is the only university to receive two grants to the same institution.

“The next pandemic isn’t a question of ‘if,’ but ‘when,’” said OU Vice President for Research and Partnerships Tomás Díaz de la Rubia. “Research at the University of Oklahoma is going to help society be better prepared and responsive to future health challenges.”

Next-Generation Surveillance

David Ebert, Ph.D., professor of computer science and electrical and computer engineering in the Gallogly College of Engineering, is the principal investigator on one of the projects, which explores new ways of sharing, integrating and analyzing data using new and traditional data sources. Ebert is also the director of the Data Institute for Societal Challenges at OU, which applies OU expertise in data science, artificial intelligence, machine learning and data-enabled research to solving societal challenges.

While emerging pathogens can circulate among wild or domestic animals before crossing over to humans, the delayed response to the COVID-19 pandemic has highlighted the need for new early detection methods, more effective data management, and integration and information sharing between officials in both public and animal health.

Ebert’s team, composed of experts in data science, computer engineering, public health, veterinary sciences, microbiology and other areas, will look to examine data from multiple sources, such as veterinarians, agriculture, wastewater, health departments, and outpatient and inpatient clinics, to potentially build algorithms to detect the spread of signals from one source to another. The team will develop a comprehensive animal and public health surveillance, planning and response roadmap that can be tailored to the unique needs of communities.

“Integrating and developing new sources of data with existing data sources combined with new tools for detection, localization and response planning using a One Health approach could enable local and state public health partners to respond more quickly and effectively to reduce illness and death,” Ebert said. “This planning grant will develop proof-of-concept techniques and systems in partnership with local, state and regional public health officials and create a multistate partner network and design for a center to prevent the next pandemic.”

The Centers for Disease Control and Prevention describes One Health as an approach that bridges the interconnections between people, animals, plants and their shared environment to achieve optimal health outcomes.

Co-principal investigators on the project include Michael Wimberly, Ph.D., professor in the College of Atmospheric and Geographic Sciences; Jason Vogel, Ph.D., director of the Oklahoma Water Survey and professor in the Gallogly College of Engineering School of Civil Engineering and Environmental Science; Thirumalai Venkatesan, director of the Center for Quantum Research and Technology in the Dodge Family College of Arts and Sciences; and Aaron Wendelboe, Ph.D., professor in the Hudson College of Public Health at the OU Health Sciences Center.

Predicting and Preventing the Next Avian Influenza Pandemic

Several countries have experienced deadly outbreaks of avian influenza, commonly known as bird flu, that have resulted in the loss of billions of poultry, thousands of wild waterfowl and hundreds of humans. Researchers at the University of Oklahoma are taking a unique approach to predicting and preventing the next avian influenza pandemic.

Xiangming Xiao, Ph.D., professor in the Department of Microbiology and Plant Biology and director of the Center for Earth Observation and Modeling in the Dodge Family College of Arts and Sciences, is leading a project to assemble a multi-institutional team that will explore pathways for establishing an International Center for Avian Influenza Pandemic Prediction and Prevention.

The goal of the project is to incorporate and understand the status and major challenges of data, models and decision support tools for preventing pandemics. Researchers hope to identify future possible research and pathways that will help to strengthen and improve the capability and capacity to predict and prevent avian influenza pandemics.

“This grant is a milestone in our long-term effort for interdisciplinary and convergent research in the areas of One Health (human-animal-environment health) and big data science,” Xiao said. “This is an international project with geographical coverage from North America, Europe and Asia; thus, it will enable OU faculty and students to develop greater ability, capability, capacity and leaderships in prediction and prevention of global avian influenza pandemic.”

Other researchers on Xiao’s project include co-principal investigators A. Townsend Peterson, Ph.D., professor at the University of Kansas; Diann Prosser, Ph.D., research wildlife ecologist for the U.S. Geological Survey; and Richard Webby, Ph.D., director of the World Health Organization Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds with St. Jude Children’s Research Hospital. Wayne Marcus Getz, professor at the University of California, Berkeley, is also assisting on the project.

The National Science Foundation grant for Ebert’s research is set to end Jan. 31, 2024, while Xiao’s grant will end Dec. 31, 2023.


Read More

Continue Reading

Spread & Containment

Pfizer vaults into sickle cell market as GBT deal confirmed

Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT)  has been confirmed, with the
The post Pfizer…

Published

on

Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT)  has been confirmed, with the $68.50-per-share deal valuing GBT at $5.4 billion.

As we reported this morning, the deal gives Pfizer already-approved SCD therapy Oxbryta (voxelator) – which industry watchers reckon could see a dramatic uptick in sales with Pfizer’s marketing muscle – plus a phase 3 antibody candidate, a phase 1 follow-up to Oxbryta that could offer improved dosing.

Oxbryta is the main asset in the deal, with Evaluate predicting sales could reach $1.5 billion in 2028 – a leap forward from the $195 million it made last year and $127 million in the first half of 2022.

Pfizer is expecting big things from the takeover , predicting that the company’s SCD franchise will bring in combined peak sales of more than $3 billion.

The boards of both companies have recommended the deal to shareholders, and the two companies suggested it should close before the end of the year – assuming of course it doesn’t fall foul of any antitrust issues raised by financial regulators.

The GBT deal comes at a time when the market for SCD therapies is undergoing significant change, with multiple new drugs reaching the market after years of stagnation and progress also being made with genetic therapies from the likes of bluebird bio, Vertex Pharma/CRISPR Therapeutics and Precision Bio/Novartis.

Oxbryta came to market in 2019, a few days after Novartis’ injectable anti-P-selectin antibody Adakveo (crizanlizumab), which is also tipped for blockbuster sales but like Oxbryta has suffered from a slow rollout.

CRISPR Therapeutics and Vertex are also in the running with their gene-editing candidate CTX001, in phase 1/2 trials which are due to generate final results later this year. If those results are positive the partners have said they could file for approval in the US before year-end.

Meanwhile, bluebird bio’s one-time gene therapy  lovotibeglogene autotemcel is supposed to be heading for regulatory filing in the US next year, although it has been delayed by an FDA partial clinical hold implemented after a persistent case of anaemia was seen in one adolescent patient in a clinical trial.

GBT’s inclacumab – another P-selectin antibody that could encroach on Adakveo – is in a pair of phase 3 trials due to generate results next year.

Meanwhile, there are a couple of orally-active pyruvate kinase R activators from Forma Therapeutics and Agios – etavopivat and mitapivat, respectively – in mid-stage development, and Pfizer has its own SCD candidate in PF-07209326, an E-selectin anatomist in phase 1.

It’s worth noting that this isn’t Pfizer’s first deal in SCD. In 2011 it paid $340 million for rights to rivipansel, a pan-selectin antagonist developed by GlycoMimetics, which failed a phase 3 test in 2019 and was jettisoned by Pfizer the following year.

The deal is another example of Pfizer splashing out on business development thanks to windfall cash generated by its COVID-19 vaccine Comirnaty and oral antiviral therapy Paxlovid. It comes shortly after the group closed a $6.7 billion acquisition of Arena Pharma, bringing on board etrasimod in late-stage testing for ulcerative colitis, and made an $11.6 billion takeover bid for Biohaven and its migraine therapy Nurtec ODT (rimegepant).

The post Pfizer vaults into sickle cell market as GBT deal confirmed appeared first on .

Read More

Continue Reading

Trending